It is also approved for adults who are overweight with at least one weight-related health condition, such as diabetes or high blood pressure
Data on lifetime, occupational history, smoking history, general health conditions, previous diseases and other anamnesis data were obtained through interviews
Holliday MW Jr, Frost L, Navaneethan SD
In clinical trials, liraglutide showed a placebo-corrected weight loss of around 5%, semaglutide 12%, and tirzepatide 18% [23]
By using cutting-edge technology and drawing on extensive knowledge of physicochemical qualities, our team of seasoned experts optimizes solubility and stability
In 2026, the focus has moved toward GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide) receptor agonists